Bordetella pertussis Antibody, IgG by ELISA with Reflex to Immunoblot

Also known as: BORDG

Clinical Use

Use

This test is used to provide evidence of vaccination or past infection with Bordetella pertussis. However, it does not determine immunity to B. pertussis. It's important to note that serology testing is not generally recommended for diagnosing active pertussis infections. The CDC recommends Bordetella pertussis/parapertussis by PCR and/or Bordetella pertussis Culture as first-line tests for suspected cases of pertussis. Positive results in this test may indicate a current or recent exposure or immunization against B. pertussis.

Special Instructions

Not provided.

Limitations

The test cannot determine immunity to Bordetella pertussis and is not recommended for diagnosing active infections. The specificity of the ELISA may not differentiate between current infection and past immunization or exposure. Although the test offers a semi-quantitative evaluation, equivocal results may require repeat testing to confirm. Exposure to Bordetella pertussis should be correlated with clinical presentation and history for accurate assessment.

Test Details

Methodology

Immunoassay (ELISA)

Biomarkers

Bordetella pertussis IgG

Antibody

IV Measurement

Concentration / Level • Ordinal Score (e.g., TPS, CPS, H-score)

LOINC Codes

Order Codes

42330-1 - B pert IgG Ser IA-aCnc

Result Turnaround Time

1-5 days

Specimen

Serum

Volume

1 mL

Minimum Volume

0.1 mL

Container

ARUP Standard Transport Tube

Collection Instructions

Separate serum from cells ASAP or within 2 hours of collection. Transfer serum to the transport tube for testing. Clearly label specimens as 'acute' or 'convalescent'.